Endocrinology, Vol 120, 1750-1757, Copyright © 1987 by Endocrine Society

ARTICLES

Phasic effects of glucose, phospholipase A2, and lysophospholipids on insulin secretion

WY Fujimoto and SA Metz

Arachidonic acid and lysophospholipids generated by glucose stimulation of phospholipase A2 may be related to the biphasic pattern of insulin secretion. Therefore, we examined the effects of glucose, exogenous phospholipase A2, lysophospholipids, and pharmacological agents which perturb the reesterification or oxygenation of arachidonic acid in superfused monolayer cultures of neonatal rat islet cells. Nordihydroguaiaretic acid (20 microM), an inhibitor of islet lipoxygenase, significantly decreased phasic glucose-stimulated insulin secretion, especially during phase 1, suggesting that stimulatory lipoxygenase metabolites of arachidonic acid contribute to the effects of glucose stimulation. Treatment with exogenous phospholipase A2 (10 mU/ml) or melittin (1.0 or 2.0 micrograms/ml) to generate arachidonic acid and lysophospholipids de novo caused a monophasic release of insulin, followed by a gradual decline in insulin secretion despite the continued presence of these agonists. Conversely, p- hydroxymercuribenzoate (15, 30, and 50 microM), which blocks the reacylation of lysophospholipids with arachidonic acid, evoked a concentration-dependent biphasic stimulation of insulin secretion which was reversible. Lipoxygenase inhibition had no effect upon phase 1 secretion by p-hydroxymercuribenzoate, although it did partially reduce phase 2 secretion. However, lysophosphatidylcholine (50, 75, and 100 micrograms/ml) also caused a concentration-dependent biphasic stimulation of insulin secretion which resembled that seen with p- hydroxymercuribenzoate, suggesting that lysophospholipids were mediating the effects of p-hydroxymercuribenzoate. We speculate that during glucose stimulation of the islet, the following three phospholipase A2-initiated changes may be important: generation of lysophospholipid to stimulate directly insulin secretion, generation of arachidonic acid and lipoxygenase-mediated arachidonate metabolites, which positively modulate insulin secretion, and generation of cyclooxygenase-mediated arachidonate metabolites, which negatively modulate insulin secretion.

This article has been cited by other articles:

				Z. Wang, S. Ramanadham, Z. A. Ma, S. Bao, D. J. Mancuso, R. W. Gross, and J. Turk Group VIA Phospholipase A2 Forms a Signaling Complex with the Calcium/Calmodulin-dependent Protein Kinase II{beta} Expressed in Pancreatic Islet {beta}-Cells J. Biol. Chem., February 25, 2005; 280(8): 6840 - 6849. [Abstract] [Full Text] [PDF]

				K. Song, X. Zhang, C. Zhao, N. T. Ang, and Z. A. Ma Inhibition of Ca2+-Independent Phospholipase A2 Results in Insufficient Insulin Secretion and Impaired Glucose Tolerance Mol. Endocrinol., February 1, 2005; 19(2): 504 - 515. [Abstract] [Full Text] [PDF]

				K. W. Huggins, A. C. Boileau, and D. Y. Hui Protection against diet-induced obesity and obesity- related insulin resistance in Group 1B PLA2-deficient mice Am J Physiol Endocrinol Metab, November 1, 2002; 283(5): E994 - E1001. [Abstract] [Full Text] [PDF]

				P. Gilon and J.-C. Henquin Mechanisms and Physiological Significance of the Cholinergic Control of Pancreatic {beta}-Cell Function Endocr. Rev., October 1, 2001; 22(5): 565 - 604. [Abstract] [Full Text] [PDF]